High-dose intravenous methylprednisolone therapy for patients with Diamond-Blackfan anemia refractory to conventional doses of prednisone
Authors:
- Juan M. CarrilloJCJuan M. Carrillo
- George R. BuchananGBGeorge R. Buchanan
- 31 October 1995
- journal article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 127 (4) , 654-659
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Long-term survival and cure after marrow transplantation for congenital hypoplastic anaemia (Diamond-Blackfan syndrome)British Journal of Haematology, 1993
- High‐dose methylprednisolone sodium succinate as a single agent in relapsed childhood acute lymphoblastic leukaemiaMedical and Pediatric Oncology, 1992
- HIGH DOSE INTRAVENOUS METHYLPREDNISOLONE FOR ACQUIRED APLASTIC ANAEMIA, DIAMOND-BLACKFAN SYNDROME AND AREGENERATIVE ANAEMIASBritish Journal of Haematology, 1989
- Aseptic osteonecroses in the treatment of childhood acute leukaemiasEuropean Journal of Pediatrics, 1989
- Cyclosporine therapy of aplastic anaemia, congenital and acquired red cell aplasiaBritish Journal of Haematology, 1989
- High-dose intravenous methylprednisolone therapy for anemia associated with diaphyseal dysplasiaThe Journal of Pediatrics, 1989
- Cytotoxic immunosuppressive drug treatment strategy in pure red cell aplasiaEuropean Journal of Haematology, 1988
- High-Dose Intravenous Corticosteroid Treatment for Patients with Diamond-Blackfan Syndrome Resistant or Refractory to Conventional TreatmentJournal of Pediatric Hematology/Oncology, 1988
- Diamond-Blackfan Syndrome. II. In Vitro Corticosteroid Effect on ErythropoiesisPediatric Research, 1982
- Severe Aplastic Anaemia: Correlation of in Vitro Tests with Clinical Response to Immunosuppression in 20 PatientsBritish Journal of Haematology, 1981